Fabrinet enters its August 17 earnings print in an unusual position: short sellers are actively cutting exposure into the report, not building it.
Short interest has dropped nearly 9% over the past week to 4.6% of free float — about 1.66 million shares — the lowest level in roughly six weeks. That retreat accelerated on August 11, when short positions fell more than 9% in a single session. The borrow market tells the same story. Cost to borrow has eased sharply, down 33% on the week to just 0.39%, its lowest reading in the 30-day window. Availability is exceptionally loose at 2,874%, meaning for every share currently borrowed short, roughly 29 more sit available in the lending pool. There is no squeeze pressure here, and shorts appear to be stepping aside ahead of the print rather than pressing a thesis.
Options positioning supports that picture, though with a slight wrinkle. The put/call ratio has moved modestly lower from its recent peak, running at 0.83 — slightly below its 20-day average of 0.89, and about 0.7 standard deviations beneath it. A month ago the PCR was running above 1.25, a notably more defensive stance. The drift lower through July into August tracks almost exactly with the rally the stock posted over the same period — up 11.6% on the month — as hedges were unwound and call interest recovered relative to puts. Overall, positioning looks more constructive than cautious, though not aggressively so.
The Street presents a more mixed picture ahead of Monday's report. The most recent analyst action came on July 22, when Needham trimmed its target from $800 to $650 while holding a Buy — a meaningful cut that reflects post-Q3 caution even from bulls. The consensus mean target sits at $732, implying roughly 39% upside from the current price of $525.88, though that figure is skewed by targets set before the stock's May selloff. JP Morgan carries a Neutral and a $680 target. Barclays remains Overweight with a $702 target. The bull case centres on Fabrinet's position in advanced optical packaging for AI and HPC workloads, a business that beat estimates last quarter and has driven 90-day EPS momentum into the 85th percentile of the universe. The bear case is structural: heavy reliance on a small number of key customers, limited supplier optionality, and the need to forecast demand far ahead of actual orders. Valuation is not cheap — the stock trades at 26.5x trailing earnings and 21.5x EV/EBITDA, both up roughly 8-10% over the past month — though the P/E has expanded on price strength rather than estimate cuts.
Earnings history adds a note of caution that the short-covering alone cannot fully offset. In each of the past three reported quarters, Fabrinet fell on the day of results — down 5.4%, 6.5%, and 11.4% respectively. The five-day move was negative in all three cases as well, ranging from -0.3% to -11.6%. The pattern is consistent enough to warrant attention: even when results beat headline estimates, the stock has struggled to hold gains in the days that follow. Peers are moving in different directions ahead of the report, offering limited directional read-through. COHR gained 1.5% on the week while JBL posted a strong 4.9% gain. CLS fell 17.4% — by far the biggest move in the group — suggesting name-specific catalysts are dominating sector-level signals rather than a clean macro tide.
The key question for next week is whether Fabrinet's AI-linked optical volumes can deliver a revenue and margin outcome that breaks the post-earnings selloff pattern — and whether guidance is strong enough to move the consensus target meaningfully above $650.
See the live data behind this article on ORTEX.
Open FN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
